GlaxoSmithKline recently announced that it will discontinue the practice of paying physicians to promote its pharmaceuticals and medical devices.It will also no longer pay its sales staff based on the number of prescriptions a doctor writes.
It’s certainly a bold move. Pay-for-promotion, so-to-speak, has been a common tactic in the pharmaceutical and medical device industries’ educati